Niemann-Pick Type C-2 Disease: Identification by Analysis of Plasma Cholestane-3β,5α,6β-Triol and Further Insight into the Clinical Phenotype.

[1]  E. Bertini,et al.  A new simple and rapid LC-ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[2]  Xuefan Gu,et al.  Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease , 2014, Journal of Lipid Research.

[3]  F. Sedel,et al.  Niemann-Pick disease type C symptomatology: an expert-based clinical description , 2013, Orphanet Journal of Rare Diseases.

[4]  E. Elahi,et al.  Identification of mutation in NPC2 by exome sequencing results in diagnosis of Niemann-Pick disease type C. , 2013, Molecular genetics and metabolism.

[5]  F. Sedel,et al.  Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. , 2012, Molecular genetics and metabolism.

[6]  Anneliese O. Speak,et al.  A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma[S] , 2011, Journal of Lipid Research.

[7]  C. Vite,et al.  Cholesterol Oxidation Products Are Sensitive and Specific Blood-Based Biomarkers for Niemann-Pick C1 Disease , 2010, Science Translational Medicine.

[8]  A. Shabani,et al.  Successful allogeneic bone marrow transplant for Niemann–Pick disease type C2 is likely to be associated with a severe ‘graft versus substrate’ effect , 2010, Journal of Inherited Metabolic Disease.

[9]  E. Ikonen,et al.  Respiratory disease in Niemann‐Pick type C2 is caused by pulmonary alveolar proteinosis , 2010, Clinical genetics.

[10]  M. Baumgartner,et al.  Recommendations on the diagnosis and management of Niemann-Pick disease type C. , 2009, Molecular genetics and metabolism.

[11]  J. Storch,et al.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking. , 2009, Biochimica et biophysica acta.

[12]  B. Bembi,et al.  Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone , 2008, Journal of cellular and molecular medicine.

[13]  G. Millat,et al.  Niemann–Pick C disease: functional characterization of three NPC2 mutations and clinical and molecular update on patients with NPC2 , 2007, Clinical genetics.

[14]  S. Pfeffer,et al.  Clues to Neuro-Degeneration in Niemann-Pick Type C Disease from Global Gene Expression Profiling , 2006, PloS one.

[15]  F. Krummenauer,et al.  Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann–Pick disease type A/B and C , 2006, Journal of Inherited Metabolic Disease.

[16]  G. Millat,et al.  Niemann-Pick C disease: use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families. , 2005, Molecular genetics and metabolism.

[17]  H. Klein,et al.  Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2 , 2002, Annals of neurology.

[18]  K. Higaki,et al.  Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. , 2001, American journal of human genetics.

[19]  Y. Ioannou,et al.  Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. , 1999, Molecular genetics and metabolism.

[20]  T. Baba,et al.  A porcine homolog of the major secretory protein of human epididymis, HE1, specifically binds cholesterol. , 1999, Biochimica et biophysica acta.

[21]  M. Vanier,et al.  Early-lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group , 1998, European Journal of Pediatrics.

[22]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[23]  W. J. Johnson,et al.  Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. , 1995, Journal of lipid research.

[24]  C. Hollak,et al.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. , 1994, The Journal of clinical investigation.

[25]  R. Rousson,et al.  Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. , 1991, Biochimica et biophysica acta.

[26]  R. Brady,et al.  Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[28]  M. Minczuk,et al.  Two siblings with myopathy, mild mental retardation and combined OXPHOS deficiencies caused by a mutation in the gene encoding asparaginyl tRNA synthetase, NARS2 , 2014 .

[29]  J. E. Wraith,et al.  Developmental outcome post allogenic bone marrow transplant for Niemann Pick Type C2. , 2013, Molecular genetics and metabolism.